Diabetes

New immunotherapy trial for Type 1 diabetes

The search for a treatment for Type 1 diabetes (T1D) - which affects over 400,000 people in the UK – will be stepped up with the start of a new phase one clinical trial at Guy's Hospital in London.

Diabetes

Promising vaccine strategy for type 1 diabetes extended to humans

A molecule that prevents Type 1 diabetes in mice has provoked an immune response in human cells, according to researchers at National Jewish Health and the University of Colorado. The findings, published online in the Proceedings ...

Diabetes

Researchers dig for cause of dog diabetes

(HealthDay)—Like many other animals, man's best friend isn't immune to developing diabetes. But new research suggests that while the disease in dogs looks similar to type 1 diabetes in people, there are some significant ...

Diabetes

Insulin vaccine for type 1 diabetes undergoes second trial

A vaccination against type 1 diabetes will soon also be available to young children: the Pre-POINTearly vaccination study will involve children between the ages of six months and two years from across Germany who have a first-degree ...

Diabetes

Clinical trial for type 1 diabetes begins at JGH, MUHC

Investigators at Montreal's Lady Davis Institute at the Jewish General Hospital and McGill University Health Centre have announced the start of a landmark clinical study aimed at restoring normal insulin secretion in people ...

Genetics

Eye color may indicate risk for serious skin conditions

Eye color may be an indicator of whether a person is high-risk for certain serious skin conditions. A study, led by the University of Colorado School of Medicine, shows people with blue eyes are less likely to have vitiligo. ...

page 1 from 18